 Tzu Phang
Concepts (329)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Glucocorticoid | 4 | 2017 | 155 | 0.440 |
Why?
| | Gene Expression Profiling | 15 | 2014 | 1774 | 0.430 |
Why?
| | Software | 5 | 2013 | 665 | 0.420 |
Why?
| | Databases, Genetic | 3 | 2009 | 237 | 0.370 |
Why?
| | Gene Expression Regulation | 9 | 2017 | 2607 | 0.360 |
Why?
| | Mammary Glands, Animal | 3 | 2006 | 129 | 0.300 |
Why?
| | Chorionic Gonadotropin | 5 | 2000 | 80 | 0.290 |
Why?
| | Alternative Splicing | 1 | 2009 | 229 | 0.280 |
Why?
| | Receptors, LH | 4 | 2000 | 9 | 0.270 |
Why?
| | Nuclear Proteins | 3 | 2017 | 712 | 0.250 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2017 | 66 | 0.250 |
Why?
| | Oligonucleotide Array Sequence Analysis | 12 | 2014 | 767 | 0.250 |
Why?
| | Face | 3 | 2017 | 173 | 0.220 |
Why?
| | Computational Biology | 4 | 2013 | 644 | 0.210 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2022 | 87 | 0.180 |
Why?
| | Dog Diseases | 2 | 2012 | 64 | 0.170 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 267 | 0.170 |
Why?
| | Precancerous Conditions | 1 | 2021 | 169 | 0.160 |
Why?
| | Hemangiosarcoma | 2 | 2010 | 21 | 0.160 |
Why?
| | Hermanski-Pudlak Syndrome | 1 | 2019 | 2 | 0.160 |
Why?
| | Precision Medicine | 1 | 2024 | 429 | 0.160 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 66 | 0.150 |
Why?
| | Respiratory System | 2 | 2017 | 157 | 0.150 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2017 | 860 | 0.150 |
Why?
| | Pulmonary Alveoli | 2 | 2012 | 405 | 0.150 |
Why?
| | Database Management Systems | 2 | 2009 | 51 | 0.150 |
Why?
| | Systems Biology | 2 | 2017 | 67 | 0.150 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2012 | 1396 | 0.140 |
Why?
| | Phospholipase C delta | 1 | 2017 | 5 | 0.140 |
Why?
| | Maxillofacial Development | 1 | 2017 | 18 | 0.130 |
Why?
| | Proteins | 3 | 2000 | 1009 | 0.130 |
Why?
| | Airway Remodeling | 1 | 2017 | 64 | 0.130 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.130 |
Why?
| | Muscle, Smooth | 1 | 2017 | 155 | 0.130 |
Why?
| | Cluster Analysis | 4 | 2010 | 499 | 0.130 |
Why?
| | Mesoderm | 1 | 2017 | 144 | 0.120 |
Why?
| | Photoaffinity Labels | 3 | 2000 | 6 | 0.120 |
Why?
| | Transcription Factor RelA | 1 | 2016 | 87 | 0.120 |
Why?
| | DNA Copy Number Variations | 2 | 2021 | 182 | 0.120 |
Why?
| | Saccharopine Dehydrogenases | 1 | 2015 | 3 | 0.120 |
Why?
| | Proline Oxidase | 1 | 2015 | 6 | 0.120 |
Why?
| | Pulmonary Fibrosis | 1 | 2019 | 402 | 0.120 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 345 | 0.120 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2017 | 138 | 0.120 |
Why?
| | Gene Expression | 3 | 2016 | 1502 | 0.120 |
Why?
| | Response Elements | 1 | 2015 | 91 | 0.110 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2014 | 27 | 0.110 |
Why?
| | Dogs | 3 | 2012 | 413 | 0.110 |
Why?
| | Transcription Factor AP-2 | 1 | 2014 | 82 | 0.110 |
Why?
| | Cleft Lip | 1 | 2014 | 52 | 0.110 |
Why?
| | Gene Dosage | 1 | 2014 | 140 | 0.110 |
Why?
| | Cleft Palate | 1 | 2014 | 68 | 0.110 |
Why?
| | DNA-Binding Proteins | 2 | 2014 | 1502 | 0.110 |
Why?
| | Internet | 2 | 2009 | 655 | 0.110 |
Why?
| | Lactation | 2 | 2006 | 181 | 0.110 |
Why?
| | Lung Neoplasms | 2 | 2021 | 2526 | 0.110 |
Why?
| | Transcription, Genetic | 3 | 2015 | 1457 | 0.100 |
Why?
| | Cell Line | 6 | 2016 | 2847 | 0.100 |
Why?
| | Gene Regulatory Networks | 3 | 2013 | 305 | 0.100 |
Why?
| | Antiporters | 2 | 2003 | 22 | 0.100 |
Why?
| | Introns | 1 | 2014 | 258 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2019 | 1164 | 0.100 |
Why?
| | Epithelial Cells | 2 | 2016 | 1096 | 0.100 |
Why?
| | Lymphoma, T-Cell | 1 | 2012 | 25 | 0.100 |
Why?
| | NF-kappa B | 2 | 2014 | 691 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 496 | 0.100 |
Why?
| | Growth Hormone-Secreting Pituitary Adenoma | 1 | 2012 | 11 | 0.090 |
Why?
| | Mice | 12 | 2021 | 17787 | 0.090 |
Why?
| | Iodine Radioisotopes | 5 | 2000 | 145 | 0.090 |
Why?
| | Lymphoma, B-Cell | 1 | 2012 | 106 | 0.090 |
Why?
| | Animals | 17 | 2021 | 36940 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2016 | 976 | 0.090 |
Why?
| | Transcriptome | 2 | 2017 | 971 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 455 | 0.090 |
Why?
| | Immunity, Innate | 3 | 2012 | 828 | 0.090 |
Why?
| | Databases, Nucleic Acid | 1 | 2010 | 34 | 0.090 |
Why?
| | Comparative Genomic Hybridization | 1 | 2010 | 30 | 0.090 |
Why?
| | Philadelphia Chromosome | 1 | 2010 | 18 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2012 | 148 | 0.080 |
Why?
| | Genomics | 2 | 2024 | 795 | 0.080 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 69 | 0.080 |
Why?
| | NFATC Transcription Factors | 1 | 2010 | 95 | 0.080 |
Why?
| | Down-Regulation | 2 | 2010 | 657 | 0.080 |
Why?
| | Influenza A virus | 1 | 2011 | 107 | 0.080 |
Why?
| | Reoviridae | 1 | 2010 | 37 | 0.080 |
Why?
| | Dexamethasone | 3 | 2017 | 368 | 0.080 |
Why?
| | Encephalitis, Viral | 1 | 2010 | 43 | 0.080 |
Why?
| | Adenoma | 1 | 2012 | 230 | 0.080 |
Why?
| | Reoviridae Infections | 1 | 2010 | 54 | 0.080 |
Why?
| | Wnt Proteins | 1 | 2010 | 133 | 0.080 |
Why?
| | Alcohol-Related Disorders | 1 | 2010 | 122 | 0.080 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 122 | 0.080 |
Why?
| | Humans | 28 | 2024 | 137585 | 0.080 |
Why?
| | Breeding | 1 | 2009 | 64 | 0.080 |
Why?
| | Algorithms | 2 | 2009 | 1704 | 0.080 |
Why?
| | Neovascularization, Pathologic | 1 | 2010 | 301 | 0.080 |
Why?
| | Biomarkers, Tumor | 2 | 2012 | 1276 | 0.070 |
Why?
| | Estrogen Receptor alpha | 1 | 2009 | 145 | 0.070 |
Why?
| | Sequence Analysis, DNA | 1 | 2011 | 812 | 0.070 |
Why?
| | RNA Polymerase II | 3 | 2017 | 324 | 0.070 |
Why?
| | Macrophages, Alveolar | 1 | 2010 | 391 | 0.070 |
Why?
| | Data Collection | 1 | 2010 | 673 | 0.070 |
Why?
| | Pregnenolone Carbonitrile | 1 | 2006 | 2 | 0.070 |
Why?
| | Blood Platelets | 1 | 2010 | 408 | 0.070 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2900 | 0.070 |
Why?
| | Bacterial Proteins | 2 | 2003 | 879 | 0.060 |
Why?
| | Sleep | 1 | 2013 | 755 | 0.060 |
Why?
| | Receptors, Steroid | 1 | 2006 | 50 | 0.060 |
Why?
| | Models, Statistical | 1 | 2010 | 669 | 0.060 |
Why?
| | Up-Regulation | 2 | 2006 | 843 | 0.060 |
Why?
| | Influenza, Human | 1 | 2012 | 622 | 0.060 |
Why?
| | Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2016 | 11 | 0.060 |
Why?
| | Neoadjuvant Therapy | 1 | 2008 | 404 | 0.060 |
Why?
| | Inflammation | 2 | 2014 | 2837 | 0.060 |
Why?
| | Cell Nucleus | 1 | 2008 | 620 | 0.060 |
Why?
| | RNA, Messenger | 6 | 2010 | 2833 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2008 | 405 | 0.060 |
Why?
| | Mutagenesis | 3 | 2002 | 179 | 0.050 |
Why?
| | Lung | 2 | 2010 | 4060 | 0.050 |
Why?
| | Calcium | 1 | 2010 | 1199 | 0.050 |
Why?
| | Macrophages | 1 | 2012 | 1547 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 1 | 2008 | 557 | 0.050 |
Why?
| | Alcoholism | 1 | 2010 | 807 | 0.050 |
Why?
| | Models, Biological | 3 | 2012 | 1783 | 0.050 |
Why?
| | Protein Binding | 3 | 2016 | 2224 | 0.050 |
Why?
| | Transcription Factors | 2 | 2009 | 1719 | 0.050 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5757 | 0.050 |
Why?
| | Signal Transduction | 6 | 2015 | 5079 | 0.050 |
Why?
| | Hemangioma, Cavernous | 1 | 2003 | 15 | 0.050 |
Why?
| | Pregnancy, Animal | 1 | 2003 | 52 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2006 | 518 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 102 | 0.050 |
Why?
| | Cells, Cultured | 4 | 2017 | 4193 | 0.050 |
Why?
| | Cell Membrane | 2 | 2006 | 738 | 0.050 |
Why?
| | Tetracycline Resistance | 1 | 2002 | 5 | 0.050 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 452 | 0.050 |
Why?
| | Intracranial Arteriovenous Malformations | 1 | 2003 | 50 | 0.050 |
Why?
| | HLA-A Antigens | 1 | 2022 | 55 | 0.050 |
Why?
| | Female | 14 | 2021 | 73304 | 0.050 |
Why?
| | Binding Sites | 4 | 2015 | 1303 | 0.050 |
Why?
| | Mitochondria | 1 | 2008 | 948 | 0.050 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 431 | 0.050 |
Why?
| | Histocompatibility Antigens | 1 | 2022 | 105 | 0.050 |
Why?
| | Laser Capture Microdissection | 1 | 2021 | 33 | 0.050 |
Why?
| | Brain | 2 | 2013 | 2668 | 0.050 |
Why?
| | Amino Acid Sequence | 3 | 2003 | 2139 | 0.050 |
Why?
| | Liver | 2 | 2006 | 1943 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 3958 | 0.040 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2022 | 203 | 0.040 |
Why?
| | Base Sequence | 2 | 2015 | 2181 | 0.040 |
Why?
| | Blotting, Western | 2 | 2016 | 1226 | 0.040 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2022 | 367 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 160 | 0.040 |
Why?
| | Chemokines | 2 | 2012 | 228 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 539 | 0.040 |
Why?
| | STAT1 Transcription Factor | 2 | 2011 | 72 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 600 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2016 | 1242 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2019 | 32 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 852 | 0.040 |
Why?
| | Breast Neoplasms | 2 | 2009 | 2253 | 0.040 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1062 | 0.040 |
Why?
| | Apoptosis | 3 | 2014 | 2553 | 0.040 |
Why?
| | Promoter Regions, Genetic | 2 | 2015 | 1250 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4295 | 0.040 |
Why?
| | Haplotypes | 1 | 2019 | 494 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2019 | 341 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 1998 | 217 | 0.030 |
Why?
| | Jaw | 1 | 2017 | 26 | 0.030 |
Why?
| | Hypertrophy | 1 | 2017 | 133 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2017 | 127 | 0.030 |
Why?
| | Nose | 1 | 2017 | 67 | 0.030 |
Why?
| | Primary Cell Culture | 1 | 2017 | 171 | 0.030 |
Why?
| | Tongue | 1 | 2017 | 81 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2017 | 269 | 0.030 |
Why?
| | Adenoviridae | 1 | 2017 | 193 | 0.030 |
Why?
| | Pregnancy | 3 | 2006 | 6763 | 0.030 |
Why?
| | Acetic Acid | 1 | 1996 | 18 | 0.030 |
Why?
| | Autoradiography | 1 | 1996 | 78 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 1996 | 106 | 0.030 |
Why?
| | Hypoxia | 1 | 2003 | 1112 | 0.030 |
Why?
| | Acetates | 1 | 1996 | 99 | 0.030 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 86 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2014 | 2475 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2017 | 665 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2017 | 480 | 0.030 |
Why?
| | Exons | 2 | 2010 | 355 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 469 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2014 | 316 | 0.030 |
Why?
| | Prognosis | 2 | 2012 | 4030 | 0.030 |
Why?
| | Bronchi | 1 | 2015 | 260 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 2 | 2010 | 916 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2003 | 1238 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4565 | 0.030 |
Why?
| | Enkephalins | 1 | 2013 | 20 | 0.030 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2013 | 9 | 0.030 |
Why?
| | Education | 1 | 2013 | 108 | 0.030 |
Why?
| | Cartilage | 1 | 2014 | 188 | 0.030 |
Why?
| | Prealbumin | 1 | 2013 | 30 | 0.030 |
Why?
| | Cytokines | 2 | 2012 | 2085 | 0.030 |
Why?
| | RNA, Neoplasm | 1 | 2012 | 82 | 0.020 |
Why?
| | Myosins | 1 | 2013 | 135 | 0.020 |
Why?
| | Male | 8 | 2013 | 67762 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 409 | 0.020 |
Why?
| | Protein Precursors | 1 | 2013 | 134 | 0.020 |
Why?
| | Cell Line, Tumor | 2 | 2010 | 3412 | 0.020 |
Why?
| | Lectins, C-Type | 1 | 2012 | 67 | 0.020 |
Why?
| | Models, Molecular | 3 | 2003 | 1570 | 0.020 |
Why?
| | Protein Structure, Secondary | 2 | 2003 | 374 | 0.020 |
Why?
| | Exome | 1 | 2013 | 231 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2014 | 378 | 0.020 |
Why?
| | Bone and Bones | 1 | 2014 | 317 | 0.020 |
Why?
| | DNA Mutational Analysis | 2 | 2003 | 399 | 0.020 |
Why?
| | Glucocorticoids | 1 | 2016 | 594 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 891 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2012 | 318 | 0.020 |
Why?
| | Middle Aged | 5 | 2012 | 33479 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 346 | 0.020 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2010 | 16 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 686 | 0.020 |
Why?
| | Genes, Neoplasm | 1 | 2010 | 22 | 0.020 |
Why?
| | Bronchoalveolar Lavage | 1 | 2010 | 93 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2013 | 327 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2010 | 99 | 0.020 |
Why?
| | Imatinib Mesylate | 1 | 2010 | 79 | 0.020 |
Why?
| | Caspases, Effector | 1 | 2010 | 2 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2012 | 510 | 0.020 |
Why?
| | Surface-Active Agents | 1 | 2011 | 91 | 0.020 |
Why?
| | Dasatinib | 1 | 2010 | 54 | 0.020 |
Why?
| | Markov Chains | 1 | 2010 | 126 | 0.020 |
Why?
| | Fibroblasts | 1 | 2015 | 996 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2010 | 195 | 0.020 |
Why?
| | Thiazoles | 1 | 2010 | 123 | 0.020 |
Why?
| | Amino Acid Motifs | 2 | 2000 | 225 | 0.020 |
Why?
| | Phagocytosis | 1 | 2012 | 380 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2013 | 660 | 0.020 |
Why?
| | Interferon Regulatory Factors | 1 | 2010 | 39 | 0.020 |
Why?
| | ras Proteins | 1 | 2010 | 153 | 0.020 |
Why?
| | Demography | 1 | 2010 | 291 | 0.020 |
Why?
| | Quality Control | 1 | 2009 | 172 | 0.020 |
Why?
| | Benzamides | 1 | 2010 | 216 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1916 | 0.020 |
Why?
| | Amino Acid Substitution | 2 | 2000 | 307 | 0.020 |
Why?
| | Inheritance Patterns | 1 | 2009 | 45 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2006 | 2486 | 0.020 |
Why?
| | Cyclosporine | 1 | 2010 | 268 | 0.020 |
Why?
| | Organ Specificity | 1 | 2009 | 305 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2009 | 232 | 0.020 |
Why?
| | RNA Splicing | 1 | 2010 | 269 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2009 | 71 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2011 | 366 | 0.020 |
Why?
| | Blotting, Northern | 1 | 2008 | 201 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 955 | 0.020 |
Why?
| | Kinetics | 1 | 2012 | 1670 | 0.020 |
Why?
| | Interferons | 1 | 2010 | 202 | 0.020 |
Why?
| | Perilipin-1 | 1 | 2008 | 17 | 0.020 |
Why?
| | Estrogen Receptor Modulators | 1 | 2008 | 17 | 0.020 |
Why?
| | Ethanol | 1 | 2013 | 608 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 466 | 0.020 |
Why?
| | S100 Proteins | 1 | 2008 | 37 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1389 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2010 | 652 | 0.020 |
Why?
| | Cell Communication | 1 | 2009 | 315 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2010 | 622 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 658 | 0.020 |
Why?
| | Piperazines | 1 | 2010 | 350 | 0.020 |
Why?
| | Biomedical Research | 1 | 2013 | 692 | 0.020 |
Why?
| | Tamoxifen | 1 | 2008 | 202 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 363 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 992 | 0.020 |
Why?
| | Pyrimidines | 1 | 2010 | 470 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 601 | 0.020 |
Why?
| | Adult | 4 | 2012 | 37929 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 1178 | 0.020 |
Why?
| | Phenotype | 1 | 2014 | 3196 | 0.020 |
Why?
| | Time Factors | 2 | 2009 | 6828 | 0.020 |
Why?
| | Rats | 2 | 2006 | 5647 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2012 | 1431 | 0.020 |
Why?
| | Chromatin | 1 | 2009 | 519 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2008 | 338 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2009 | 528 | 0.010 |
Why?
| | Membrane Transport Proteins | 1 | 2006 | 162 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2010 | 890 | 0.010 |
Why?
| | Quantitative Trait Loci | 1 | 2007 | 380 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 436 | 0.010 |
Why?
| | Dietary Fats | 1 | 2006 | 304 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 15657 | 0.010 |
Why?
| | Research Design | 1 | 2011 | 1139 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2008 | 771 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1738 | 0.010 |
Why?
| | Sequence Analysis, Protein | 1 | 2003 | 30 | 0.010 |
Why?
| | Milk Proteins | 1 | 2003 | 34 | 0.010 |
Why?
| | Osteopontin | 1 | 2003 | 33 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2011 | 1991 | 0.010 |
Why?
| | Stromal Cells | 1 | 2003 | 112 | 0.010 |
Why?
| | Smoking | 1 | 2011 | 1627 | 0.010 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2008 | 801 | 0.010 |
Why?
| | Sulfhydryl Reagents | 1 | 2002 | 12 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2003 | 159 | 0.010 |
Why?
| | Corpus Callosum | 1 | 2003 | 71 | 0.010 |
Why?
| | Temporal Arteries | 1 | 2003 | 45 | 0.010 |
Why?
| | Temporal Lobe | 1 | 2003 | 91 | 0.010 |
Why?
| | Disease Progression | 1 | 2010 | 2757 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 5742 | 0.010 |
Why?
| | Frontal Lobe | 1 | 2003 | 149 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3284 | 0.010 |
Why?
| | Plasmids | 1 | 2002 | 363 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2006 | 2167 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 2002 | 570 | 0.010 |
Why?
| | Cysteine | 1 | 2002 | 204 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 1692 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 861 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2426 | 0.010 |
Why?
| | Serine | 1 | 2000 | 141 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2000 | 239 | 0.010 |
Why?
| | Tyrosine | 1 | 2000 | 222 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2000 | 234 | 0.010 |
Why?
| | Gene Deletion | 1 | 2000 | 391 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 7635 | 0.010 |
Why?
| | Lipids | 1 | 2003 | 672 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 815 | 0.010 |
Why?
| | Aged | 2 | 2011 | 23961 | 0.010 |
Why?
| | Protein Conformation | 1 | 2000 | 934 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2003 | 1086 | 0.010 |
Why?
| | Antibodies | 1 | 1998 | 410 | 0.010 |
Why?
| | Young Adult | 1 | 2010 | 13209 | 0.010 |
Why?
| | Hypertension, Pulmonary | 1 | 2003 | 1910 | 0.010 |
Why?
| | Adolescent | 1 | 2003 | 21513 | 0.000 |
Why?
| | Child | 1 | 2003 | 21935 | 0.000 |
Why?
|
|
Phang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|